MAPT and Alzheimer disease: In this review we highlight the elevated levels of mRNA expression of LRP-1, App, Bace1, Mapt and Cdk5 genes, Sp1, Sp3, GSK3β, protein phosphatases and CLDN5 proteins that can be used as novel markers in diagnosis of AD.